The effect of transcutaneous auricular vagus nerve stimulation on cardiovascular function in subarachnoid hemorrhage patients: a safety study.

Gansheng TanAnna L HuguenardKara M DonovanPhillip DemarestXiaoxuan LiuZiwei LiMarkus AdamekKory LavineAnanth K VellimanaTerrance T KummerJoshua W OsbunGregory J ZipfelPeter BrunnerEric C Leuthardt

Published in: medRxiv : the preprint server for health sciences (2024)

Transcutaneous auricular vagus nerve stimulation (taVNS) treatment is a safe immunomodulatory treatment approach for subarachnoid hemorrhage patients.taVNS treatment did not induce adverse cardiovascular effects, such as bradycardia or QT prolongation.An acute increase in heart rate after taVNS treatment may serve as a biomarker for SAH patients who could derive greater benefit from this treatment.

Keyphrases

subarachnoid hemorrhage
heart rate
brain injury
end stage renal disease
chronic kidney disease
newly diagnosed
emergency department
heart rate variability
cerebral ischemia
patient reported outcomes